These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 5059235)

  • 1. Re-investigation of the effect of adrenaline and noradrenaline on renal function in situ.
    Liang CC; Yang MM
    J Physiol; 1972 Jan; 220(1):19-32. PubMed ID: 5059235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog: marked tachyphylaxis to angiotensin.
    Richardson PD; Withrington PG
    Br J Pharmacol; 1977 Feb; 59(2):293-301. PubMed ID: 837016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog.
    Richardson PD; Withrington PG
    J Physiol; 1978 Sep; 282():451-70. PubMed ID: 722550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation of hepatic vascular resistance sites in the isolated dual-perfused rat liver.
    Yang W; Benjamin IS; Alexander B
    Eur J Pharmacol; 1999 Jan; 364(1):13-21. PubMed ID: 9920180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of adrenaline and noradrenaline on venous return and regional blood flows in the anaesthetized cat with special reference to intestinal blood flow.
    Greenway CV; Lawson AE
    J Physiol; 1966 Oct; 186(3):579-95. PubMed ID: 5972154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intraportal infusions of glucagon on the hepatic arterial and portal venous vascular beds of the dog: inhibition of hepatic arterial vasoconstrictor reponses to noradrenaline.
    Richardson PD; Withrington PG
    Pflugers Arch; 1978 Dec; 378(2):135-40. PubMed ID: 569834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of stimulation of the hepatic nerves, infusions of noradrenaline and occlusion of the carotid arteries on liver blood flow in the anaesthetized cat.
    Greenway CV; Lawson AE; Mellander S
    J Physiol; 1967 Sep; 192(1):21-41. PubMed ID: 6051805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal pressure responses to catecholamines.
    Brungardt JM; Reynolds DG; Swan KG
    Proc Soc Exp Biol Med; 1972 May; 140(1):24-9. PubMed ID: 4402378
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamines increase urine formation in isolated toad (Bufo marinus) kidneys perfused at constant rate.
    Morris JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(1):219-25. PubMed ID: 6149872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.
    Richardson PD; Withrington PG
    Br J Pharmacol; 1977 Jun; 60(2):239-49. PubMed ID: 195661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics of experimental portal venous occlusion in dogs.
    Kerr JC; Reynolds DG; Swan KG
    Am Surg; 1975 Apr; 41(4):198-202. PubMed ID: 1122071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental distribution of vascular resistances during ureteral occlusion. The vasoconstrictive effects of angiotensin and CaCl2 differ from those of catecholamines and renal nerve stimulation.
    Vikse A; Holdaas H; Hartmann A; Kiil F
    Acta Physiol Scand; 1983; 119(2):147-58. PubMed ID: 6140816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of catecholamines and adrenoceptor blocking drugs on the canine peripheral lymph flow.
    De Micheli P; Glässer AH
    Br J Pharmacol; 1975 Apr; 53(4):499-504. PubMed ID: 238702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion.
    Anderson RJ; Cronin RE; McDonald KM; Schrier RW
    J Clin Invest; 1976 Oct; 58(4):964-70. PubMed ID: 965499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bilateral antidiuresis to renal artery infusion of prostaglandin E1 in dogs treated with phenylbutazone.
    Hall WJ; Hensey OJ; O'Neill P; Sheehan JD
    J Physiol; 1978 Aug; 281():1-13. PubMed ID: 702355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic, pulmonary and mesenteric perfusion and oxygenation effects of dopamine and epinephrine.
    Cheung PY; Barrington KJ; Pearson RJ; Bigam DL; Finer NN; Van Aerde JE
    Am J Respir Crit Care Med; 1997 Jan; 155(1):32-7. PubMed ID: 9001285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion.
    Schrier RW; Berl T
    J Clin Invest; 1973 Feb; 52(2):502-11. PubMed ID: 4683886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.
    Zelis R; Mansour EJ; Capone RJ; Mason DT
    J Clin Invest; 1974 Dec; 54(6):1247-58. PubMed ID: 4612057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the hyperglycaemic and glycogenolytic responses to catecholamines with those to stimulation of the hepatic sympathetic innervation in the dog.
    Edwards AV; Silver M
    J Physiol; 1972 Jun; 223(2):571-93. PubMed ID: 5039287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of substance P on various vascular beds in the dog.
    Hallberg D; Pernow B
    Acta Physiol Scand; 1975 Feb; 93(2):277-85. PubMed ID: 1146575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.